Brain Health
Gut Bacteria Trigger ALS and Dementia Through Toxic Sugar Production
Scientists discover harmful bacterial sugars in the gut trigger immune attacks that damage the brain in ALS and dementia patients.
Press Release
Apr 10, 2026 0
All Articles
802 articles
Nutrition & Diet
Spice Combinations Boost Anti-Inflammatory Power 100-Fold in New Study
Researchers find that mixing compounds from mint, chili peppers, and eucalyptus creates synergistic anti-inflammatory effects far beyond individual spices.
Press Release
Apr 10, 2026 0
Nutrition & Diet
Cooling Potatoes Cuts Blood Sugar Spike by 40% Through Resistant Starch Formation
Chilling cooked potatoes transforms starch into resistant form, dramatically lowering glycemic impact compared to hot potatoes.
Press Release
Apr 10, 2026 0
Longevity & Aging
Hydrogen Sulfide Gas Shows Promise as New Alzheimer's Treatment Target
Johns Hopkins researchers find that a protein producing 'rotten egg' gas in tiny amounts may protect memory and prevent brain damage.
Press Release
Apr 10, 2026 0
Longevity & Aging
NAD+ Combination Therapy Restores Muscle and Bone Function in Aging Mice
New research shows combining NMN supplementation with apigenin effectively reverses age-related muscle and bone decline in mice.
Press Release
Apr 10, 2026 0
Longevity & Aging
Life Biosciences Raises $80M to Advance Epigenetic Reprogramming Therapy
Boston biotech secures major funding to complete Phase 1 trials of ER-100, a therapy targeting aging through epigenetic reprogramming.
Press Release
Apr 10, 2026 0
Longevity & Aging
First Patient Receives RNA-Editing Therapy for Rare Genetic Lung Disease
Airna begins Phase 1 trial of AIR-001, an RNA-editing treatment for alpha-1 antitrypsin deficiency affecting lung and liver health.
Press Release
Apr 10, 2026 0
Longevity & Aging
NeuroTherapia's NTRX-07 Shows Promise in Alzheimer's Phase 2a Trial
New oral drug candidate completes safety trial in 48 Alzheimer's patients, marking potential breakthrough in neurodegenerative disease treatment.
Press Release
Apr 10, 2026 0
Longevity & Aging
Merck Invests $838M in Antibody Startup for Longevity Drug Development
Pharmaceutical giant Merck's massive investment in 10-person biotech Infinimmune signals Big Pharma's serious push into longevity therapeutics.
Press Release
Apr 10, 2026 0
Longevity & Aging
Finnish Biotech Awards $30K to Cleveland Clinic for Organ Transplant Research
NADMED funds groundbreaking research on metabolic assessment of donor organs, advancing redox biology toward real-world longevity medicine.
Press Release
Apr 10, 2026 0
Longevity & Aging
Annovis Advances Buntanetap to Phase 3 Alzheimer's Trial After Unusual Drug History
Biotech company traces its lead Alzheimer's drug candidate from unexpected origins to Phase 3 clinical trials.
Press Release
Apr 10, 2026 0
Longevity & Aging
Eating Disorders Leave Lasting Health Impacts That Accelerate Aging
New research reveals how eating disorders create long-term biological damage affecting bone density, heart health, and cognitive function throughout life.
Press Release
Apr 9, 2026 0